(Q46002180)

18 December 2017

title

Dosimetry of 223Ra-chloride: dose to normal organs and tissues. (English)

1 reference

18 December 2017

author

Michael Lassmann

series ordinal

1

1 reference

18 December 2017

author name string

Dietmar Nosske

series ordinal

2

1 reference

18 December 2017

publication date

11 October 2012

1 reference

18 December 2017

number of pages

6

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

18 December 2017

volume

40

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

207-212

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-012-2265-y

exact match

0 references

cites work

High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2265-Y

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2265-Y

First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2265-Y

A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2265-Y

Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2265-Y

MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2265-Y

A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2265-Y

Therapy of ankylosing spondylitis with 224Ra-radium chloride: dosimetry and risk considerations.

21 January 2018

1 reference

12 December 2020

Age-dependent doses to members of the public from intake of radionuclides: Part 4. Inhalation dose coefficients. A report of a task group of Committee 2 of the International Commission on Radiological Protection

1 reference

12 December 2020

Age-dependent doses to members of the public from intake of radionuclides: Part 2. Ingestion dose coefficients. A report of a Task Group of Committee 2 of the International Commission on Radiological Protection

1 reference

12 December 2020

Human alimentary tract model for radiological protection. ICRP Publication 100. A report of The International Commission on Radiological Protection

1 reference

12 December 2020

Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases

1 reference

12 December 2020

EANM procedure guideline for treatment of refractory metastatic bone pain

1 reference

12 December 2020

Alpha-particle doses to cells of the bone remodeling cycle from alpha-particle-emitting bone-seekers: indications of an antiresorptive effect of actinides

1 reference

12 December 2020

10.1007/S00259-012-2265-Y

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017